StumbleUpon | fdapills's comments & reviews

Love Potion and Viagra For Women Healthy Living | Health Ranker

Sat, 12 Apr 2008 02:07:22 -0700

FDA Internet Pharmacy is offering pink Viagra on online shelves. At the forefront of this over the counter movement is Viagra's approval - gathered a group of what she calls like-minded feminists. Their goal: to educate about the female medication of women's sexuality.

http://fdapills.stumbleupon.com/review/19267326/

Fri, 28 Mar 2008 13:58:53 -0700

Online RX pharmacies is proud to announce the creation of a new website, dedicated to provide with tramadol to US online customers. For discount coupons contact Tramadol

Tramadol no prescription is dedicated to the muscle relaxants and pain relievers delivery, through our US licensed pharmacies, and offers you the great FedEx next day delivery option. Tramadol no prescription.com is open to you 24/7 days a week, and you can order anytime, in your own time, with No prior prescription needed! Now you can enjoy the convenience of ordering from your own home and forget about waiting for doctors.

Tramadol no prescription.com works only with US licensed pharmacies and US licensed physicians, all our medications are approved by the FDA. After you fill out the order a licensed physician will review the information you have submitted and your medical conditions to approve or deny your order. If your order is approved the doctor will write a prescription and dispatch your order through FeDEX next day delivery option.

Tramadol no prescription.com offers you complete privacy on all your orders, and a safe and secure transaction server, you can contact tramadol no prescription.com at any time either by clicking the Live Help button for a live chat session with our customer service staff.

To apply for unlimited 5% and 10% discount coupons write US

http://fdapills.stumbleupon.com/review/17499771/

Sat, 16 Feb 2008 06:58:32 -0800

and more:
http://www.google.com/reader/shared/10102628975355123629
http://picasaweb.google.com/maxidrom11
http://www.kiva.org/lender/breeolson
http://www.last.fm/user/approveddrugs
http://www.linkedin.com/in/buyonline
http://www.pownce.com/pillsonline/
http://twitter.com/breeolson
http://www.zorpia.com/breeolson/journals/1307
http://www.youtube.com/user/nadiasynn
http://breeolson.suprglu.com/
http://www.plugim.com/user/discount/
http://www.diigo.com/profile/discountpills
http://www.blinklist.com/reliable/
http://mystuff.ask.com/public/maxidrom11/folders/Pharmacy
http://peachyforum.com/members/BigMaxidrom.aspx
http://www.grazr.com/user/viagraprice
http://www.webproworld.com/members/cheapdrugs.html
http://www.carroll.edu/boards/member.php?u=9239
http://www.webmasterworld.com/profilev4.cgi?action=view&member=eMax
http://www.v7n.com/forums/members/maxidrom11.html
http://www.spock.com/Bree-Olson-MkXCg1NzI
http://www.aqmd.gov/forum/Default.aspx?g=profile&u=122

http://fdapills.stumbleupon.com/review/17499675/

Sat, 16 Feb 2008 06:54:31 -0800

I have to say -- I am very active online and made many social profiles for last month:
check them out if you want:

http://digg.com/users/pharmacy11
http://www.flickr.com/people/drugspills/
http://www.myspace.com/pillsonline
http://sphinn.com/user/view/profile/login/FDA
http://searchles.com/people/show/fdadrugs
http://technorati.com/people/technorati/spunkmouth
http://www.bibsonomy.org/user/onlinedrugs
http://faves.com/users/fdaapproved
http://www.facebook.com/profile.php?id=1052799224
http://wink.com/p/Max_Shol
http://www.simpy.com/user/fdapillsonline
http://rawsugar.com/user_account/user_profile?username=rxprescription
http://ma.gnolia.com/people/fdarx
http://www.propeller.com/member/erection/
http://www.netscape.com/member/erection/
http://www.indianpad.com/user/fdameds/bookmarks
http://furl.net/member/onlinedrugs
http://reddit.com/user/maxidrom11
http://lipstick.com/user/fdameds/
http://fdapills.stumbleupon.com/
http://www.webmaster-talk.com/members/maxidrom11-36995.html
http://www.answerbag.com/profile/?id=272382
http://www.mybloglog.com/buzz/members/vigra/
http://www.bebo.com/MakL4
http://del.icio.us/onlinerx
http://profiles.friendster.com/drugsrx
http://vigra.blogs.friendster.com/
http://www.jumpcut.com/levitra11
http://www.mybloglog.com/buzz/community/fdarxnews/

http://fdapills.stumbleupon.com/review/17089526/

Wed, 06 Feb 2008 13:34:49 -0800

First, I want to say I found this nice prednisone pill blog online ...
Rheumatoid arthritis treatment patients with severe morning stiffness appeared to benefit more from a prednisone formulation that delivered the drug while they slept than from taking the same dose on awakening, researchers found.

Action Points * Explain to patients who ask that a delayed-release formulation of prednisone when taken at bedtime was more effective for reducing joint stiffness than a same-dose standard pill taken in the morning.

* Note that the formulation is still investigational. In a phase 3 study, the mean relative change in the duration of morning stiffness over 12 weeks improved by about 22% with the modified-release prednisone (Lodotra) versus the standard formulation, Frank Buttgereit, M.D., of Charit� University Medicine here, and colleagues, reported in the Jan. 19 issue of The Lancet. Although glucocorticoids still have substantial risks, they are essential for successful treatment of some disorders. In an attempt to "sharpen the old spear," the researchers studied a way to improve treatment with conventional glucocorticoid drugs using a modified-release tablet. The tablet, taken late in the evening, delivered the prednisone about four hours after ingestion. Chronotherapy in this form adapts to the circadian rhythms of endogenous cortisol and disease symptoms, both of which peak during the early morning hours, the investigators said. The total drug exposure and maximum concentrations were almost identical in the modified and standard formulations. Only the time points of release differed, since prednisone doses in individual patients were not changed. The findings came from a multicenter, randomized, double-blind trial of 288 men and women, ages 18 to 89, with active rheumatoid arthritis. The patients, primarily older and female, were recruited from 17 centers in Germany and 12 centers in Poland from August 2004 through April 6, 2006. All patients suffered morning joint stiffness of at least 45 minutes and had an average daily maximum pain intensity score of 30 mm or more on a 100-mm visual analog scale. All patients had been on prednisone for at least three months before the study and on a stable dose for at least one month. Of the patients, 144 were randomly assigned to modified-release prednisone tablets, to be taken between 9:30 and 10:30 p.m., and the same number were assigned to an immediate-release tablet taken between 6 and 8 a.m.; each group took two tablets a day at the two time points, one a dummy tablet. Patients filled out symptom diaries recording the duration of morning stiffness in the joints, and the researchers calculated the mean relative change in the duration of stiffness at 12 weeks versus baseline. The change in duration of morning stiffness was significantly higher with modified-release prednisone than with immediate-release prednisone (-22.7% versus -0.4%, difference: 22.4%, 95% CI: 0.49 to 44.30, P=0.045). Patients taking the modified-release pill achieved a mean reduction of 44.0 minutes (SD: 136.6) compared with baseline. The absolute difference between the treatment groups at 12 weeks was 29.2 min, (95% CI: -2.59 to 61.9) in favor of the modified-release formulation (P=0.072). The safety profiles did not differ between treatments. Improvement in morning stiffness with the modified-release drug was already evident after two weeks of treatment with a difference of 10% between the two treatment groups, the researchers wrote. With continued treatment, this difference increased and reached a plateau at around 38% from week seven until the end of the 12-week treatment period. No clinically relevant differences were noted between the two treatment groups for secondary variables, with the exception of proinflammatory cytokine interleukin 6, which was decreased in the modified-release group but remained constant for the immediate-release patients. Further studies are needed to investigate long-term effects of specially timed drug release on basic inflammatory processes and the entire range of symptoms of rheumatoid arthritis, including pain, the researchers said. In addition to the favorable effect on morning joint stiffness, these studies need to clarify whether the new preparation allows a specific dose of the glucocorticoid to be more effective or less deleterious, or both. The investigators stressed that patients need to be carefully advised with regard to the correct timing of this evening drug to achieve the beneficial effect in clinical practice. This new formulation might also be an option for the treatment of other diseases such as polymyalgia rheumatica, which is also characterized by severe early morning symptoms, or even asthma, they conclude

http://fdapills.stumbleupon.com/review/16358652/

Sat, 19 Jan 2008 04:03:10 -0800

Higher education was a major issue discussed, and the four Columbia legislators, hailing from a town with three colleges or universities, felt that more could be done than the governor recommends.
Blunt’s plans for higher education include capital improvements, a 4.4 percent increase in the operating budgets of public colleges and universities and $100 million more for scholarships.
Despite the 4.4 increase, the local legislators feel it isn’t enough.
“The governor has dug this state into such a deep hole,” Rep. Jeff Harris, D-Columbia, said. “What he said is too little too late.”
Harris said he’d like to make tuition at public colleges and universities tax deductible and to get the funding back to a much higher level. He said public higher education should be the top priority this session.
Ted Farnen, the chief of staff for Sen. Chuck Graham, D-Columbia, said the senator was disappointed with Blunt’s address.
“They could’ve made higher education a higher priority,” Farnen said. “It’s hard to fathom the university doesn’t have as much money to work with as it did back in 2002.”
Rep. Ed Robb, R-Columbia, who has long been a proponent of funding for the Ellis Fischel Cancer Center in Columbia, was happy to hear Blunt recommend $31 million for renovation and construction to the hospital, but hopes to attain more funding in that area.
“I’d like to add some additional monies to that,” Robb said. “About $52 million would bring us to the amount we need.”
Attorney General Jay Nixon gave the Democratic response on Tuesday night, following Blunt’s address, and chastised the governor for the way he has handled higher education.
“As tuition soars, Gov. Blunt and his allies have allowed Missouri to slide to dead last in our investment in higher education,” Nixon said.
Despite a backlash of criticism following the address, higher education leaders commended Blunt for his commitment to education.
UM system Interim President Gordon Lamb prepared a statement to applaud Blunt’s higher education investments, and the Coordinating Board for Higher Education was also appreciative.
“The additional support means our colleges and universities will be better positioned to meet challenges associated with increasing access and success of prospective students and ensuring Missouri produces a truly global workforce that will meet our future needs,” CBHE chairwoman Kathryn Swan said.
Health care was discussed extensively, and Blunt laid out his ideas to improve access to affordable care. He mentioned his Insure Missouri and Mo HealthNet programs, which seek to strengthen the climate of health care in the state.
Blunt said unlike the “old system,” HealthNet is about results.
Robb supported Blunt’s plans, but Democratic legislators were strongly opposed to it.
“He said he wants to save the safety net,” House Minority Leader Paul LeVota said. “He cut a hole in that net in 2005.”
The “hole” LeVota mentioned references cuts Blunt made to health care in his first year as governor, which took coverage away from thousands of Missourians, primarily children, seniors and people with disabilities.
Although Blunt is working to improve health care in Missouri, House democrats don’t believe Blunt’s proposals will restore the cuts made in 2005.
“If you do have the money to work with why don’t we restore the services cut in 2005?” Farnen said. “We already know who the people are that need help, so why not help them?”
Rep. Judy Baker, D-Columbia, said Blunt’s plans would do nothing to restore the cuts and said she will work hard this session to make health care a priority.
Health care and education will undoubtedly be among the most debated issues this session, but Blunt continues to tout change.
“Change is working,” he said. “Missourians are prospering.”